Literature DB >> 20530498

Racial differences in postprandial mineral ion handling in health and in chronic kidney disease.

Orlando M Gutiérrez1, Tamara Isakova, Kelsey Smith, Michael Epstein, Neha Patel, Myles Wolf.   

Abstract

BACKGROUND: Increased serum phosphate is associated with cardiovascular disease. Compared with whites, blacks have significantly higher serum phosphate and increased risk of hyperphosphataemia in health and chronic kidney disease (CKD). While population-based studies suggest that diminished urinary phosphorus excretion in blacks may explain these differences, few physiological studies explored the potential mechanisms. The aim of this study was to examine racial differences in postprandial urinary mineral ion excretion in health and in CKD.
METHODS: Twenty-eight healthy (18 white and 10 black) and 19 CKD (9 white and 10 black) subjects consumed a standardized meal; after which, blood and urine samples were collected for 4 h for measurement of phosphate, calcium, parathyroid hormone (PTH) and fibroblast growth factor 23 (FGF23).
RESULTS: Although serum phosphate did not differ by race, blacks had ∼30% lower postprandial fractional excretion of phosphate than whites in health (P < 0.001) and CKD (P = 0.02). Similarly, blacks had ∼35% lower fractional excretion of calcium in health (P = 0.02) and CKD (P = 0.3). Moreover, the postprandial response in serum calcium among CKD subjects differed by race (P = 0.03), with serum calcium significantly decreasing in whites but not blacks.
CONCLUSIONS: Blacks had lower fractional excretion of phosphate than whites despite similar levels of PTH and FGF23 in health and in CKD, suggesting racial variability in renal sensitivity to phosphaturic hormones. Furthermore, blacks defend postprandial serum calcium more effectively than whites in CKD. Further studies are needed to define the mechanisms underlying these observations and evaluate whether racial differences in mineral ion handling may contribute to disparities in CKD outcomes.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20530498      PMCID: PMC3108369          DOI: 10.1093/ndt/gfq316

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  35 in total

1.  Racial differences in bone turnover and calcium metabolism in adolescent females.

Authors:  R J Bryant; M E Wastney; B R Martin; O Wood; G P McCabe; M Morshidi; D L Smith; M Peacock; C M Weaver
Journal:  J Clin Endocrinol Metab       Date:  2003-03       Impact factor: 5.958

2.  Vitamin D insufficiency and hyperparathyroidism in a low income, multiracial, elderly population.

Authors:  S S Harris; E Soteriades; J A Coolidge; S Mudgal; B Dawson-Hughes
Journal:  J Clin Endocrinol Metab       Date:  2000-11       Impact factor: 5.958

3.  NPT2a--the key to phosphate homeostasis.

Authors:  Henry M Kronenberg
Journal:  N Engl J Med       Date:  2002-09-26       Impact factor: 91.245

4.  Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies.

Authors:  Daniel E Weiner; Hocine Tighiouart; Manish G Amin; Paul C Stark; Bonnie MacLeod; John L Griffith; Deeb N Salem; Andrew S Levey; Mark J Sarnak
Journal:  J Am Soc Nephrol       Date:  2004-05       Impact factor: 10.121

5.  Impact of activated vitamin D and race on survival among hemodialysis patients.

Authors:  Myles Wolf; Joseph Betancourt; Yuchiao Chang; Anand Shah; Ming Teng; Hector Tamez; Orlando Gutierrez; Carlos A Camargo; Michal Melamed; Keith Norris; Meir J Stampfer; Neil R Powe; Ravi Thadhani
Journal:  J Am Soc Nephrol       Date:  2008-04-09       Impact factor: 10.121

6.  A comparison of numerical integrating algorithms by trapezoidal, Lagrange, and spline approximation.

Authors:  K C Yeh; K C Kwan
Journal:  J Pharmacokinet Biopharm       Date:  1978-02

7.  Serum phosphorus levels associate with coronary atherosclerosis in young adults.

Authors:  Robert N Foley; Allan J Collins; Charles A Herzog; Areef Ishani; Philip A Kalra
Journal:  J Am Soc Nephrol       Date:  2008-11-05       Impact factor: 10.121

8.  Racial differences in the progression from chronic renal insufficiency to end-stage renal disease in the United States.

Authors:  Chi-Yuan Hsu; Feng Lin; Eric Vittinghoff; Michael G Shlipak
Journal:  J Am Soc Nephrol       Date:  2003-11       Impact factor: 10.121

9.  Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis.

Authors:  Orlando M Gutiérrez; Michael Mannstadt; Tamara Isakova; Jose Alejandro Rauh-Hain; Hector Tamez; Anand Shah; Kelsey Smith; Hang Lee; Ravi Thadhani; Harald Jüppner; Myles Wolf
Journal:  N Engl J Med       Date:  2008-08-07       Impact factor: 91.245

10.  Mineral metabolism, mortality, and morbidity in maintenance hemodialysis.

Authors:  Geoffrey A Block; Preston S Klassen; J Michael Lazarus; Norma Ofsthun; Edmund G Lowrie; Glenn M Chertow
Journal:  J Am Soc Nephrol       Date:  2004-08       Impact factor: 10.121

View more
  23 in total

1.  Demographic, dietary, and serum factors and parathyroid hormone in the National Health and Nutrition Examination Survey.

Authors:  J M Paik; W R Farwell; E N Taylor
Journal:  Osteoporos Int       Date:  2011-09-20       Impact factor: 4.507

2.  Associations of dietary phosphorus intake, urinary phosphate excretion, and fibroblast growth factor 23 with vascular stiffness in chronic kidney disease.

Authors:  Jessica Houston; Kelsey Smith; Tamara Isakova; Nicole Sowden; Myles Wolf; Orlando M Gutiérrez
Journal:  J Ren Nutr       Date:  2012-03-09       Impact factor: 3.655

3.  Genetic African Ancestry and Markers of Mineral Metabolism in CKD.

Authors:  Orlando M Gutiérrez; Afshin Parsa; Tamara Isakova; Julia J Scialla; Jing Chen; John M Flack; Lisa C Nessel; Jayanta Gupta; Keith A Bellovich; Susan Steigerwalt; James H Sondheimer; Jackson T Wright; Harold I Feldman; John W Kusek; James P Lash; Myles Wolf
Journal:  Clin J Am Soc Nephrol       Date:  2016-02-08       Impact factor: 8.237

4.  Fibroblast growth factor-23 in obese, normotensive adolescents is associated with adverse cardiac structure.

Authors:  Farah N Ali; Bonita Falkner; Samuel S Gidding; Heather E Price; Scott W Keith; Craig B Langman
Journal:  J Pediatr       Date:  2014-07-22       Impact factor: 4.406

5.  Racial differences in parathyroid hormone levels in CKD.

Authors:  Tamara Isakova
Journal:  Nephrol Dial Transplant       Date:  2012-07       Impact factor: 5.992

6.  (1-34) Parathyroid hormone infusion acutely lowers fibroblast growth factor 23 concentrations in adult volunteers.

Authors:  Orlando M Gutiérrez; Kelsey T Smith; Allison Barchi-Chung; Neha M Patel; Tamara Isakova; Myles Wolf
Journal:  Clin J Am Soc Nephrol       Date:  2012-01       Impact factor: 8.237

7.  Longitudinal evaluation of FGF23 changes and mineral metabolism abnormalities in a mouse model of chronic kidney disease.

Authors:  Jason R Stubbs; Nan He; Arun Idiculla; Ryan Gillihan; Shiguang Liu; Valentin David; Yan Hong; L Darryl Quarles
Journal:  J Bone Miner Res       Date:  2012-01       Impact factor: 6.741

Review 8.  Health Disparities in Kidney Transplantation for African Americans.

Authors:  Kimberly Harding; Tesfaye B Mersha; Phuong-Thu Pham; Amy D Waterman; Fern A Webb; Joseph A Vassalotti; Susanne B Nicholas
Journal:  Am J Nephrol       Date:  2017-08-05       Impact factor: 3.754

9.  First trimester vitamin D, vitamin D binding protein, and subsequent preeclampsia.

Authors:  Camille E Powe; Ellen W Seely; Sarosh Rana; Ishir Bhan; Jeffrey Ecker; S Ananth Karumanchi; Ravi Thadhani
Journal:  Hypertension       Date:  2010-08-23       Impact factor: 10.190

10.  Donor phosphorus levels and recipient outcomes in living-donor kidney transplantation.

Authors:  Peter C Chang; Sharmeela Saha; Amanda M Gomes; Aparna Padiyar; Kenneth A Bodziak; Emilio D Poggio; Donald E Hricik; Joshua J Augustine
Journal:  Clin J Am Soc Nephrol       Date:  2011-02-10       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.